Literature DB >> 8125665

Synovial sarcoma of the extremities.

S Y Lee1, D G Jeon, S S Kim.   

Abstract

From May 1985 to March 1990, 18 cases of Enneking's stage II synovial sarcoma of the extremities were treated by a combination of surgery and CYVADIC chemotherapy with or without radiotherapy. The average follow up was 34.7 months. The estimated 5-year survival rate was 78.4% and the continuously disease-free 5-year survival rate was 44.4%. The results were improved by adequate surgery or chemotherapy when local recurrence or metastases had developed. The combination of surgery and CYVADIC chemotherapy with or without radiotherapy was considered to be an effective method of treating this tumour.

Entities:  

Mesh:

Year:  1993        PMID: 8125665     DOI: 10.1007/bf00181702

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  13 in total

1.  SYNOVIAL SARCOMA; AN ANALYSIS OF 34 TUMORS.

Authors:  N L CADMAN; E H SOULE; P J KELLY
Journal:  Cancer       Date:  1965-05       Impact factor: 6.860

2.  Synovial sarcoma.

Authors:  R E Gerner; G E Moore
Journal:  Ann Surg       Date:  1975-01       Impact factor: 12.969

3.  Synovial sarcoma (malignant synovioma); a report of 60 cases.

Authors:  G T PACK; I M ARIEL
Journal:  Surgery       Date:  1950-12       Impact factor: 3.982

4.  A clinical and pathological staging system for soft tissue sarcomas.

Authors:  W O Russell; J Cohen; F Enzinger; S I Hajdu; H Heise; R G Martin; W Meissner; W T Miller; R L Schmitz; H D Suit
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

5.  A long-term follow-up of synovial sarcoma.

Authors:  H U Cameron; J P Kostuik
Journal:  J Bone Joint Surg Br       Date:  1974-11

6.  Analysis of 25 cases of malignant synovioma.

Authors:  M K Hampole; B A Jackson
Journal:  Can Med Assoc J       Date:  1968-11-30       Impact factor: 8.262

7.  Phase II evaluation of adriamycin in human neoplasia.

Authors:  R M O'Bryan; J K Luce; R W Talley; J A Gottlieb; L H Baker; G Bonadonna
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

Review 8.  Causes of increased survival of patients with osteosarcoma: current controversies.

Authors:  M A Simon
Journal:  J Bone Joint Surg Am       Date:  1984-02       Impact factor: 5.284

9.  Adriamycin: a new effective agent in the therapy of disseminated sarcomas.

Authors:  R S Benjamin; P H Wiernik; N R Bachur
Journal:  Med Pediatr Oncol       Date:  1975

10.  Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.

Authors:  B S Yap; L H Baker; J G Sinkovics; S E Rivkin; R Bottomley; T Thigpen; M A Burgess; R S Benjamin; G P Bodey
Journal:  Cancer Treat Rep       Date:  1980-01
View more
  1 in total

1.  The Significance of a "Close" Margin in Extremity Sarcoma: A Systematic Review.

Authors:  Ike Hasley; Yubo Gao; Amy E Blevins; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2018
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.